Jacopo Angelini

Udine, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Precision Redosing of Oritavancin: A Population Pharmacokinetic Framework to Optimize Long-Term Therapy for Complex Gram-Positive Infections.

Precision Redosing of Oritavancin: A Population Pharmacokinetic Framework to Optimize Long-Term Therapy for Complex Gram-Positive Infections.

Journal: International journal of antimicrobial agents

Published: May 13, 2026

Oritavancin as consolidation or suppressive therapy in infective endocarditis and device-related infections: real-world experience with therapeutic drug monitoring.

Oritavancin as consolidation or suppressive therapy in infective endocarditis and device-related infections: real-world experience with therapeutic drug monitoring.

Journal: JAC-antimicrobial resistance

Published: March 20, 2026

Current opinion on the potential role of liposomal amphotericin B in underexplored clinical scenarios.

Current opinion on the potential role of liposomal amphotericin B in underexplored clinical scenarios.

Journal: Clinical microbiology reviews

Published: March 13, 2026

A comparative evaluation of aztreonam-avibactam and ceftazidime-avibactam plus aztreonam for infections due to MBL-producing Enterobacterales.

A comparative evaluation of aztreonam-avibactam and ceftazidime-avibactam plus aztreonam for infections due to MBL-producing Enterobacterales.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: March 02, 2026

Real-World Experience on the Use of Eravacycline at Doses of 1 mg/kg Bodyweight and Fixed Dose Strategy in Two European Tertiary Centers.

Real-World Experience on the Use of Eravacycline at Doses of 1 mg/kg Bodyweight and Fixed Dose Strategy in Two European Tertiary Centers.

Journal: Antibiotics (Basel, Switzerland)

Published: February 22, 2026

Challenges and Opportunities for Signal Detection During Public Health Emergencies: An Historical Re-evaluation of the Disproportionality Analysis of the ADR Reporting of Anti-COVID-19 Monoclonal Antibodies in Vigibase.

Challenges and Opportunities for Signal Detection During Public Health Emergencies: An Historical Re-evaluation of the Disproportionality Analysis of the ADR Reporting of Anti-COVID-19 Monoclonal Antibodies in Vigibase.

Journal: Drug safety

Published: February 12, 2026

Perioperative Management of Biologic and Targeted Synthetic DMARDs in Orthopedic Surgery: Balancing Infection Risk and Disease Control.

Perioperative Management of Biologic and Targeted Synthetic DMARDs in Orthopedic Surgery: Balancing Infection Risk and Disease Control.

Journal: Microorganisms

Published: November 24, 2025

Management of Invasive Fungal Infection: Clinical Strategies in Critical Care from a Multidisciplinary Consensus.

Management of Invasive Fungal Infection: Clinical Strategies in Critical Care from a Multidisciplinary Consensus.

Journal: The new microbiologica

Published: October 27, 2025

Use of isavuconazole in critically ill patients in intensive care units: a prospective, observational, multicentre, cohort study.

Use of isavuconazole in critically ill patients in intensive care units: a prospective, observational, multicentre, cohort study.

Journal: JAC-antimicrobial resistance

Published: August 04, 2025

Albumin and Other Plasma Proteins in Pediatric Patients: What, When, and How Much They Influence Antimicrobial Pharmacology.

Albumin and Other Plasma Proteins in Pediatric Patients: What, When, and How Much They Influence Antimicrobial Pharmacology.

Journal: The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG

Published: July 20, 2025

Precision Daptomycin Dosing: Comparison of 3-, 2-, 1-, and 0-Concentration Sample Strategies.

Precision Daptomycin Dosing: Comparison of 3-, 2-, 1-, and 0-Concentration Sample Strategies.

Journal: Pharmacotherapy

Published: April 29, 2025

Pharmacological Modulation of NLRP3: From Therapy Personalization to Innovative Drugs.

Pharmacological Modulation of NLRP3: From Therapy Personalization to Innovative Drugs.

Journal: Frontiers in bioscience (Landmark edition)

Published: April 04, 2025

Showing 1-12 of 35

Last Updated: 09/26/2026